Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.00
+0.04 (0.45%)
Aug 13, 2026, 4:00 PM EDT - Market closed

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $238.95M in the quarter ending June 30, 2026, with 19,582.54% growth. This brings the company's revenue in the last twelve months to $303.23M, up 1,495.93% year-over-year. In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%.

Revenue (ttm)
$303.23M
Revenue Growth
+1,495.93%
P/S Ratio
5.02
Revenue / Employee
$826,232
Employees
367
Market Cap
1.52B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.